Menu
Search
|

Menu

Close
X

Cardiovascular Systems Inc CSII.OQ (NASDAQ Stock Exchange Global Select Market)

30.76 USD
+0.53 (+1.75%)
As of 2:29 AM IST
chart
Previous Close 30.23
Open 30.41
Volume 91,825
3m Avg Volume 93,825
Today’s High 31.56
Today’s Low 30.19
52 Week High 40.00
52 Week Low 20.59
Shares Outstanding (mil) 33.09
Market Capitalization (mil) 957.49
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 7 analysts

KEY STATS

Revenue (mm, USD)
FY19
56
FY18
217
FY17
205
FY16
178
FY15
182
EPS (USD)
FY19
-0.086
FY18
0.045
FY17
-0.055
FY16
-1.721
FY15
-1.040
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
33.60
Price to Sales (TTM)
vs sector
4.67
5.69
Price to Book (MRQ)
vs sector
8.03
5.11
Price to Cash Flow (TTM)
vs sector
311.28
23.53
Total Debt to Equity (MRQ)
vs sector
17.82
15.71
LT Debt to Equity (MRQ)
vs sector
17.82
11.53
Return on Investment (TTM)
vs sector
-1.38
15.05
Return on Equity (TTM)
vs sector
-1.63
16.62

EXECUTIVE LEADERSHIP

Scott Ward
Chairman of the Board, President, Chief Executive Officer, Since 2016
Salary: $650,000.00
Bonus: $477,728.00
Laurence Betterley
Chief Financial Officer, Since 2008
Salary: $379,212.00
Bonus: $181,766.00
Jeffrey Points
Chief Financial Officer, Since 2018
Salary: $275,000.00
Bonus: $88,862.00
Kevin Kenny
Chief Operating Officer, Since 2015
Salary: $261,692.00
Bonus: $144,277.00
Rhonda Robb
Chief Operating Officer, Since 2018
Salary: $450,000.00
Bonus: $104,848.00

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

1225 Old Highway 8 NW
ST. PAUL   MN   55112-6416

Phone: +1651.2591600
Site: csi360.com/

Cardiovascular Systems, Inc. is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications. Its peripheral artery disease (PAD) systems are catheter-based platforms capable of treating a range of plaque types in leg arteries both above and below the knee. Its products include Diamondback 360 Peripheral Orbital Atherectomy System (OAS) (Diamondback 360 Peripheral), the Stealth 360 OAS (Stealth 360), Diamondback 360 Peripheral, Diamondback 360 60cm Peripheral, Diamondback 360 Low Profile Peripheral, Diamondback 360 1.50 Peripheral and Diamondback 360 2.00 Peripheral. The Company's coronary arterial disease (CAD) product, Diamondback 360 Coronary OAS (Coronary OAS), is marketed as a treatment for severely calcified coronary arteries.

SPONSORED STORIES